D-0964-2015 Class III Terminated

Recalled by Reckitt Benckiser LLC — Parsippany, NJ

FDA drug recall D-0964-2015 was initiated by Reckitt Benckiser LLC on Nov 10, 2014 and is designated Class III. Reason for recall: Defective container: A customer complaint revealed the presence of a defective seal on the top of a Mucinex pouch The recall status is terminated (terminated Mar 30, 2018). Affected quantity: 155 cases (2000 pouches of 2 tablets per case).

Recall details

Product Type
Drugs
Report Date
Apr 29, 2015
Initiation Date
Nov 10, 2014
Termination Date
Mar 30, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
155 cases (2000 pouches of 2 tablets per case)

Product description

Mucinex DM (guaifenesin 600mg and dextromethorphan HBr 30mg), extended-release bi-layer tablets, 2 tablets per pouch (NDC 63824-056-72), OTC, Distributed by Reckitt Benckiser, Parsippany, NJ 07054-0224 Made in England

Reason for recall

Defective container: A customer complaint revealed the presence of a defective seal on the top of a Mucinex pouch

Distribution pattern

Nationwide

Code information

Lot BD375 exp 06/2016; BD566, BD661 exp. 08/2016

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0964-2015
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Reckitt Benckiser LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0964-2015. Report a data issue: hello@regdatalab.com.